Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Oct 4 - Oct 9
risks include gastrointestinal effects, overlapping hepatic metabolism, injection site reactions, and hypoglycaemia, with urgent review required for severe abdominal pain, jaundice, or signs of dehydration
We focus on research-backed products that promote energy, focus, and body composition support
Weeks 13 through 16 at 1.7mg: 6.8mg total
Vogt, D., Cho, K
METAOD005: A Phase IIb (randomized, double-blind, placebo-controlled) study to assess the efficacy (reduction in body weight), safety and tolerability of 12 weeks treatment with daily doses (1, 5, 10, 20 or 30 mg AOD9604) administered orally (capsules) in 300 healthy, clinically obese males, and females of non-child bearing potential, with a BMI 35 kg/m 2
US$ 23.12
US$ 28.21
US$ 27.51
US$ 20.50
